BN104 — Investigational Agent
Menin Inhibitor · Phase 1/2 · Biolino Bioscience / BioNova
Mechanism of Action
Small-molecule inhibitor of the menin-KMT2A (MLL) protein-protein interaction, disrupting the transcriptional complex that maintains leukemogenic HOX/MEIS1 programs in KMT2A-rearranged and NPM1-mutated acute leukemias.
Investigational Indications
- KMT2A-rearranged acute leukemia
- NPM1-mutated acute myeloid leukemia
- Acute lymphoblastic leukemia